Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

1.95
Delayed Data
As of Sep 30
 -0.02 / -1.02%
Today’s Change
1.72
Today|||52-Week Range
3.09
-6.70%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close1.97
Today’s open1.97
Day’s range1.94 - 1.97
Volume14,063
Average volume (3 months)41,155
Market cap$33.5M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-7.00%
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.40

Competitors

 Today’s
change
Today’s
% change
PRPHProPhase Labs Inc-0.03-1.74%
ITUSITUS Corp+0.62+18.96%
TKAITokai Pharmaceutical...-0.02-1.29%
MRNSMarinus Pharmaceutic...-0.18-9.00%
Data as of 3:59pm ET, 09/30/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
James Garner
Chief Financial Officer
Cristyn Humphreys
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts

Search for Jobs